Company: INGN
Filing Date: 2025-05-19
Form Type: 8-K
Source: 0000950170-25-074437
Chunk: 2

Company: Inogen Inc
Filing Date: 2025-05-19
Form: 8-K
Item: Item 5.07
Chunk 2
---
 adoption of the Amended and Restated 2023 Equity Incentive Plan. The votes regarding the proposal were as follows:

   Votes For      Votes Against      Abstentions      Broker Non-Votes  
 ────────────────────────────────────────────────────────────────────────
  16,489,620          1,888,391           26,394             2,533,283  

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit      Description                                                                                                            
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     10.1      Amended and Restated 2023 Equity Incentive Plan                                                                        
     10.2      Form of Stock Option Agreement under the Amended and Restated 2023 Equity Incentive Plan                               
     10.3      Form of Restricted Stock Unit Agreement (Time-Based) under the Amended and Restated 2023 Equity Incentive Plan         
     10.4      Form of Restricted Stock Unit Agreement (Performance-Based) under the Amended and Restated 2023 Equity Incentive Plan  
      104      The cover page of this Current Report on Form 8-K, formatted in inline XBRL.